Vol. 221 JOURNAL OF CONTROLLED RELEASE 10 JANUARY 2016 ...
Transcript of Vol. 221 JOURNAL OF CONTROLLED RELEASE 10 JANUARY 2016 ...
OFFICIAL JOURNAL OF THE CONTROLLED RELEASE SOCIETYAND THE JAPANESE SOCIETY OF DRUG DELIVERY SYSTEM
VOLUME 221, 10 JANUARY 2016 ISSN: 0168-3659
COVER STORYAn integrated assessment of PEGylated liposomal doxorubicin products
Vol. 221 JOURNAL OF CONTROLLED RELEASE 10 JANUARY 2016
CONTENTS
Cited in: BIOSIS/Biological Abstracts; CAB Abstracts; Chemical Abstracts Services; Current Contents (Life Sciences); EMBASE/Excerpta Medica; International Pharmaceutical Abstracts; PUBMED/MEDLINE/Index Medicus; Polymer Contents; Science Citation Index. Also covered in the abstract and citation database Scopus®. Full text available in ScienceDirect ®
Available online at www.sciencedirect.com
05054
Cover Story An integrated assessment of PEGylated liposomal doxorubicin products
K. Park (West Lafayette, USA) 71
Review What's Next for Gastrointestinal Disorders: No Needles?
A.M. Urbanska , E.D. Karagiannis , A.S. Au , S.Y. Dai , M. Mozafari and S. Prakash ( Montreal, Canada; Cambridge, New York, USA; Tehran, Iran ) 48
Research papers An integrated assessment of morphology, size, and complement activation of the PEGylated liposomal doxorubicin products
Doxil®, Caelyx®, DOXOrubicin, and SinaDoxosome P.P. Wibroe , D. Ahmadvand , M.A. Oghabian , A. Yaghmur and S.M. Moghimi ( Copenhagen Ø, Denmark; Tehran, Iran ) 1
Gold nanoparticles modified with self-assembled hybrid monolayer of triblock aptamers as a photoreversible anticoagulant S.-S. Huang , S.-C. Wei , H.-T. Chang , H.-J. Lin and C.-C. Huang ( Keelung, Taipei, Kaohsiung, Taiwan ) 9
pH-responsive and enzymatically-responsive hydrogel microparticles for the oral delivery of therapeutic proteins: Effects of protein size, crosslinking density, and hydrogel degradation on protein delivery M.C. Koetting , J.F. Guido , M. Gupta , A. Zhang and N.A. Peppas ( Austin, USA ) 18
Enhanced in vivo antitumor efficacy of dual-functional peptide-modified docetaxel nanoparticles through tumor targeting and Hsp90 inhibition Y. Jiang , N. Yang , H. Zhang , B. Sun , C. Hou , C. Ji , J. Zheng , Y. Liu and P. Zuo ( Beijing, China ) 26
Polymeric micellar nanoplatforms for Fenton reaction as a new class of antibacterial agents S.-C. Park , N.-H. Kim , W. Yang , J.-W. Nah , M.-K. Jang and D. Lee ( Suncheon, Chonbuk, Jeonju, Republic of Korea) 37
Development and characterization of sorafenib-loaded PLGA nanoparticles for the systemic treatment of liver fibrosis T.-T. Lin , D.-Y. Gao , Y.-C. Liu , Y.-C. Sung , D. Wan , J.-Y. Liu , T. Chiang , L. Wang and Y. Chen ( Hsinchu, Taiwan ) 62
Graphical Abstracts Contents Listing $doi: 10.1016/S0168-3659(15)00801-9 e1
Calendar I
Additional material available online.
3
EL
SEV
IER
JOU
RN
AL O
F C
ON
TR
OLLE
D R
ELE
AS
E
VO
L. 221 (2016) P. 1–
72
221